High-activity Natural Killer Immunotherapy for Small Metastases of Melanoma
Clinical trial NCT03007823 · COMPLETED
Trial details
- NCT number
- NCT03007823
- Sponsor
- Fuda Cancer Hospital, Guangzhou
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2017-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.